The FDA’s withdrawal of its authorization for Evusheld, a monoclonal antibody therapy used to prevent and treat Covid-19, leaves no monoclonals available for this purpose. Another monoclonal, ...
Researchers from the Johns Hopkins Bloomberg School of Public Health supported the first blood center in the U.S. to be granted full FDA approval to provide convalescent plasma to immunocompromised ...
In a recent study posted to the bioRxiv* preprint server, researchers demonstrated that coronavirus disease 2019 (COVID-19) convalescent plasmas (CCPs) with low neutralizing and high fragment ...
In a recent study posted to the medRxiv preprint server, researchers report that convalescent plasma treatment is most effective in treating hospitalized coronavirus disease 2019 (COVID-19) patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results